StockWatch
·
Pharmaceuticals
Corporate Governance13 Apr 2026, 04:51 pm

Advik Labs: Zero Investor Complaints for Q4 FY26

AI Summary

Advik Laboratories Ltd has reported that there were no investor complaints for the quarter and year ended March 31, 2026. As per Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company confirmed that zero complaints were pending at the beginning of the quarter, zero were received, zero were disposed of, and zero remained unresolved at the end of the quarter. This indicates effective investor grievance management.

Key Highlights

  • Advik Labs reported zero investor complaints for Q4 FY26.
  • No complaints were pending at the start or end of the quarter.
  • No new complaints were received or disposed of during the quarter.
  • Filing complies with SEBI Regulation 13(3).
  • Reflects strong investor grievance redressal.